scholarly journals Identification of etiologic agents of recurrent vulvovaginal candidiasis in patients from Isfahan, Iran

2020 ◽  
Vol 7 (2) ◽  
pp. e18-e18
Author(s):  
Kiana Shirani ◽  
Zahra Allameh ◽  
Azadeh Moshtzan

Introduction: Occurrence of vulvovaginal candidiasis (VVC), as a common condition in women of childbearing age, is increasing all over the world as a result of extensive use of antibiotics and antifungal drugs. Objectives: In the present study to gain the up-to-date information on involved species and the prevalence of the recurrent vulvovaginal candidiasis (RVVC) in Isfahan, Iran, we assessed the etiologic agents of aforementioned disease in women referred to the Al-Zahra hospital (Isfahan, Iran). Furthermore, we surveyed the possible relationship between age, education and marital status with prevalence of albicans and non-albicans candidiasis. Patients and Methods: Our study was conducted on subjects who were admitted to the gynecology and midwifery clinic between September 2017 and August 2018 and had clinical presentations of vulvovaginitis. Sampling of 100 women was done using sterile swab. Samples were transferred to the hospital laboratory for cellular and molecular investigations. Results:Candida albicans was the main pathogen involved in the pathogenesis of RVVC and Candida glabrata is the second most common pathogen. Moreover, none of the 100 cases that we tested were infected with Candida krusei. We found a meaningful relationship between age and RVVC triggered by Candida albicans (P<0.05) but there was no significant relationship between age and RVVC that triggered by non-albicans fungi. There was no meaningful correlation between levels of education, number of children and types of delivery with RVVC that infected by various albicans and non-albicans candidiasis (P>0.05). Conclusion:Candidaalbicans was the main pathogen involved in the pathogenesis of RVVC in Isfahan while Candida glabrata is the second most common pathogen. Despite their high cost, molecular methods have high value in accurate diagnosis of the RVVC.

2020 ◽  
Author(s):  
Lance R. Fredericks ◽  
Mark D. Lee ◽  
Cooper R. Roslund ◽  
Mason A. Shipley ◽  
Paul A. Rowley

ABSTRACTKiller toxins have a range of antifungal activities against pathogenic species of yeasts. Candida glabrata was found to be acutely susceptible to seven killer toxins produced by Saccharomyces species of yeasts. Specifically, the ionophoric K1 and K2 killer toxins were broadly inhibitory to a large collection of C. glabrata from patients with recurrent vulvovaginal candidiasis. The sensitivity of these clinical isolates to killer toxins does not correlate with their resistance to major classes of antifungal drugs.


Author(s):  
Andrea Boyd Tressler ◽  
Metabel Markwei ◽  
Chelsea Fortin ◽  
Meng Yao ◽  
Gary W. Procop ◽  
...  

2016 ◽  
Vol 8 ◽  
Author(s):  
Bruna de FREITAS ◽  
Daniela Vasconcellos Dini da Cruz PIRES

A candidíase vulvovaginal é uma doença causada pela Cândida sp, na maior parte das vezes a Cândida albicans e Cândida glabrata, e é muito comum entre as mulheres de todo o mundo. Os principais sintomas relatados são prurido intenso, disúria, dispareunia e leucorreia, causando um grande incômodo na região intima feminina. Existem alguns fatores de risco como diabetes mellitus, utilização de contraceptivos orais, utilização de roupas íntimas e gravidez. O médico pode suspeitar sobre o quadro clinico da paciente já no exame clínico e com base nos sintomas descritos por ela, mas é necessário confirmar o diagnóstico. Uma das formas de confirmação de diagnóstico para candidíase vulvovaginal é a microscopia, onde serão observados hifas e esporos. Apesar de ser uma doença muito comum entre as mulheres, é necessário um diagnóstico correto para um tratamento eficaz.


PLoS ONE ◽  
2014 ◽  
Vol 9 (9) ◽  
pp. e107805 ◽  
Author(s):  
Patricia de Souza Bonfim-Mendonça ◽  
Bianca Altrão Ratti ◽  
Janine da Silva Ribeiro Godoy ◽  
Melyssa Negri ◽  
Nayara Cristina Alves de Lima ◽  
...  

2016 ◽  
pp. 60-63 ◽  
Author(s):  
V. N. Serov ◽  
N. A. Buralkina ◽  
M. Y. Borisenko ◽  
F. Sh. Mamedova

The article tells about the key problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). Candida albicans causes 75--80% of candidiasis cases. Clinical forms of VVC include: Candida-carrying, acute VVC, chronic (recurrent) vulvovaginal candidiasis (CRVVC). The main diagnostic approaches to the treatment and prevention of recurrence of the disease are described. The authors presented data on the efficacy of the antifungal medication Diflucan in the fight against VVC.


Sign in / Sign up

Export Citation Format

Share Document